35. Medco Health Solutions
The nation's largest pharmacy benefits manager processed 898.8 million prescription orders last year, nearly a tenth of which were fulfilled through the company's burgeoning mail-order business. And though an uptick in sales of lower-priced generic drugs stymied its top line, it was more than offset by sales of higher-cost brand-name drugs and a surging number of new clients. With some $2.5 billion in cash on hand, Medco has undertaken a number of initiatives, including a stock buyback program, and opening the Medco Research Institute, a research facility to study how genetic variations respond to drugs. --P.N. |
| Key financials |
$ millions |
% change
from 2008 |
| Revenues |
59,804.2 |
16.7 |
| Profits |
1,280.3 |
16.1 |
| Assets |
17,915.5 |
— |
| Stockholders' equity |
6,387.2 |
— |
| Market value (3/26/2010) |
30,173.2 |
— |
| Profits as % of |
|
| Revenues |
2.1 |
| Assets |
7.1 |
| Stockholders' equity |
20.0 |
| Earnings per share |
|
| 2009 $ |
2.61 |
| % change from 2008 |
22.5 |
| 1999-2009 annual growth rate % |
N.A. |
| Total return to investors |
% |
| 2009 |
52.5 |
| 1999-2009 annual rate |
N.A. |
|
Galleries and videos
-
These 20 big employers have more than 60,000 job openings. What are they looking for in a new hire?
-
Even as the market soared last year, these Fortune 500 stocks delivered lousy returns to investors.
Interactives
-
See how revenues and profits at America's 25 largest companies have risen and fallen over the past decade.
-
From a single store in 1962 to more than 4,300 outlets today, see how the biggest retailer has expanded.
|
